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The nervous system detects and interprets a wide range of thermal and mechanical stimuli, as well 
as environmental and endogenous chemical irritants. When intense, these stimuli generate acute 
pain, and in the setting of persistent injury, both peripheral and central nervous system compo-
nents of the pain transmission pathway exhibit tremendous plasticity, enhancing pain signals and 
producing hypersensitivity. When plasticity facilitates protective reflexes, it can be beneficial, but 
when the changes persist, a chronic pain condition may result. Genetic, electrophysiological, 
and pharmacological studies are elucidating the molecular mechanisms that underlie detection, 
coding, and modulation of noxious stimuli that generate pain.Introduction: Acute versus Persistent Pain
The ability to detect noxious stimuli is essential to an organ-
ism’s survival and wellbeing. This is dramatically illustrated by 
examination of individuals who suffer from congenital abnor-
malities that render them incapable of detecting painful stimuli. 
These people cannot feel piercing pain from a sharp object, 
heat of an open flame, or even discomfort associated with 
internal injuries, such as a broken bone. As a result, they do not 
engage appropriate protective behaviors against these condi-
tions, many of which can be life threatening.
More commonly, alterations of the pain pathway lead to 
hypersensitivity, such that pain outlives its usefulness as an 
acute warning system and instead becomes chronic and debil-
itating. This may be seen, at some level, as an extension of 
the normal healing process, whereby tissue or nerve damage 
elicits hyperactivity to promote guarding of the injured area. 
For example, sunburn produces temporary sensitization of the 
affected area. As a result normally innocuous stimuli, such as 
light touch or warmth, are perceived as painful (a phenomenon 
referred to as allodynia), or normally painful stimuli elicit pain 
of greater intensity (referred to as hyperalgesia). At its extreme, 
the sensitization does not resolve. Indeed, individuals who suf-
fer from arthritis, postherpetic neuralgia (after a bout of shin-
gles), or bone cancer experience intense and often unremitting 
pain that is not only physiologically and psychologically debili-
tating, but may also hamper recovery. Chronic pain may even 
persist long after an acute injury, perhaps most commonly 
experienced as lower back pain or sciatica.
Persistent or chronic pain syndromes can be initiated or 
maintained at peripheral and/or central loci. In either case, the 
elucidation of molecules and cell types that underlie normal 
(acute) pain sensation is key to understanding the mecha-
nisms underlying pain hypersensitivity. In the present Review, 
we highlight the molecular complexity of the primary afferent 
nerve fibers that detect noxious stimuli. We not only summarize 
the processing of acute pain, but also describe how changes in 
pain processing occur in the setting of tissue or nerve injury.The profound differences between acute and chronic pain 
emphasize the fact that pain is not generated by an immutable, 
hardwired system, but rather results from the engagement of 
highly plastic molecules and circuits, the molecular biochemi-
cal and neuroanatomical basis of which are the focus of cur-
rent studies. Importantly, this new information has identified a 
host of potential therapeutic targets for the treatment of pain. 
We focus here on the peripheral and second order neurons in 
the spinal cord; the reader is referred to some excellent reviews 
of supraspinal pain processing mechanisms, which include 
remarkable insights that imaging studies have brought to the 
field (Apkarian et al., 2005).
Anatomical Overview
Nociception is the process by which intense thermal, mechanical, 
or chemical stimuli are detected by a subpopulation of peripheral 
nerve fibers, called nociceptors (Basbaum and Jessell, 2000). The 
cell bodies of nociceptors are located in the dorsal root ganglia 
(DRG) for the body and the trigeminal ganglion for the face, and 
have both a peripheral and central axonal branch that innervates 
their target organ and the spinal cord, respectively. Nocicep-
tors are excited only when stimulus intensities reach the noxious 
range, suggesting that they possess biophysical and molecular 
properties that enable them to detect selectively and respond to 
potentially injurious stimuli. There are two major classes of noci-
ceptors (Meyer et al., 2008). The first includes medium diameter 
myelinated (Aδ) afferents that mediate acute, well-localized “first” 
or fast pain. These myelinated afferents differ considerably from 
the larger diameter and rapidly conducting Aβ fibers that respond 
to innocuous mechanical stimulation (i.e., light touch). The sec-
ond class of nociceptor includes small diameter unmyelinated “C” 
fibers that convey poorly localized, “second” or slow pain.
Electrophysiological studies have further subdivided Aδ noci-
ceptors into two main classes. Type I (HTM: high- threshold 
mechanical nociceptors) respond to both mechanical and 
chemical stimuli but have relatively high heat thresholds (>50°C). 
If, however, the heat stimulus is maintained, these afferents will Cell 139, October 16, 2009 ©2009 Elsevier Inc. 267
Figure 1. Connections between Primary 
 Afferent Fibers and the Spinal Cord
There is a very precise laminar organization of 
the dorsal horn of the spinal cord; subsets of pri-
mary afferent fibers target spinal neurons within 
discrete laminae. The unmyelinated, peptidergic 
C (red) and myelinated Aδ nociceptors (purple) 
terminate most superficially, synapsing upon 
large projection neurons (red) located in lamina I 
and interneurons (green) located in outer lamina 
II. The unmyelinated, nonpeptidergic nociceptors 
(blue) target interneurons (blue) in the inner part of 
lamina II. By contrast, innocuous input carried by 
myelinated Aβ fibers (orange) terminates on PKCγ 
expressing interneurons in the ventral half of the 
inner lamina II. A second set of projection neurons 
within lamina V (purple) receive convergent input 
from Aδ and Aβ fibers.respond at lower temperatures. And most importantly, they will 
sensitize (i.e., the heat or mechanical threshold will drop) in the 
setting of tissue injury. Type II Aδ nociceptors have a much lower 
heat threshold, but a very high mechanical threshold. Activity 
of this afferent almost certainly mediates the “first” acute pain 
response to noxious heat. Indeed, compression block of myeli-
nated peripheral nerve fibers eliminates first, but not second, 
pain. By contrast, the type I fiber likely mediates the first pain 
provoked by pinprick and other intense mechanical stimuli.
The unmyelinated C fibers are also heterogeneous. Like the 
myelinated afferents, most C fibers are polymodal, that is, they 
include a population that is both heat and mechanically sensitive 
(CMHs) (Perl, 2007). Of particular interest are the heat-responsive, 
but mechanically insensitive, unmyelinated afferents (so-called 
silent nociceptors) that develop mechanical sensitivity only in the 
setting of injury (Schmidt et al., 1995). These afferents are more 
responsive to chemical stimuli (capsaicin or histamine) compared 
to the CMHs and probably come into play when the chemical 
milieu of inflammation alters their properties. Subsets of these 
afferents are also responsive to a variety of itch-producing pru-
ritogens. It is worth noting that not all C fibers are nociceptors. 
Some respond to cooling, and a particularly interesting popula-
tion of unmyelinated afferents responds to innocuous stroking of 
the hairy skin, but not to heat or chemical stimulation. These latter 
fibers appear to mediate pleasant touch (Olausson et al., 2008).
Neuroanatomical and molecular characterization of nocice-
ptors has further demonstrated their heterogeneity, particularly 
for the C fibers (Snider and McMahon, 1998). For example, the 
so-called “peptidergic” population of C nociceptors releases 
the neuropeptides, substance P, and calcitonin-gene related 
peptide (CGRP); they also express the TrkA neurotrophin 
receptor, which responds to nerve growth factor (NGF). The 
nonpeptidergic population of C nociceptors expresses the 
c-Ret neurotrophin receptor that is targeted by glial-derived 
neurotrophic factor (GDNF), as well as neurturin and artemin. 
A large percentage of the c-Ret-positive population also binds 
the IB4 isolectin and expresses G protein-coupled receptors 
of the Mrg family (Dong et al., 2001), as well as specific puri-268 Cell 139, October 16, 2009 ©2009 Elsevier Inc.nergic receptor subtypes, notably P2X3. Nociceptors can also 
be distinguished according to their differential expression of 
channels that confer sensitivity to heat (TRPV1), cold (TRPM8), 
acidic milieu (ASICs), and a host of chemical irritants (TRPA1) 
(Julius and Basbaum, 2001). As noted below, these function-
ally and molecularly heterogeneous classes of nociceptors 
associate with specific function in the detection of distinct pain 
modalities.
The Nociceptor: A Bidirectional Signaling Machine
One generally thinks of the nociceptor as carrying informa-
tion in one direction, transmitting noxious stimuli from the 
periphery to the spinal cord. However, primary afferent fibers 
have a unique morphology, called pseudo-unipolar, wherein 
both central and peripheral terminals emanate from a com-
mon axonal stalk. The majority of proteins synthesized by the 
DRG or trigeminal ganglion cell are distributed to both central 
and peripheral terminals. This distinguishes the primary affer-
ent neuron from the prototypical neuron, where the recipient 
branch of the neuron (the dendrite) is biochemically distinct 
from the transmission branch (the axon). The biochemical 
equivalency of central and peripheral terminals means that 
the nociceptor can send and receive messages from either 
end. For example, just as the central terminal is the locus of 
Ca2+-dependent neurotransmitter release, so the peripheral 
terminal releases a variety of molecules that influence the 
local tissue environment. Neurogenic inflammation, in fact, 
refers to the process whereby peripheral release of the neu-
ropeptides, CGRP and substance P, induces vasodilation and 
extravasation of plasma proteins, respectively (Basbaum and 
Jessell, 2000). Furthermore, whereas only the peripheral ter-
minal of the noci ceptor will respond to environmental stimuli 
(painful heat, cold, and mechanical stimulation), both the 
peripheral and central terminals can be targeted by a host of 
endogenous molecules (such as pH, lipids, and neurotrans-
mitters) that regulate its sensitivity. It follows that therapeutics 
directed at both terminals can be developed to influence the 
transmission of pain messages. For example, spinal (intrathe-
cal) delivery of morphine targets opioid receptors expressed 
by the central terminal of nociceptors, whereas topically 
applied drugs (such as local anesthetics or capsaicin) regu-
late pain via an action at the peripheral terminal.
Central Projections of the Nociceptor
Primary afferent nerve fibers project to the dorsal horn of the spinal 
cord, which is organized into anatomically and electrophysiologi-
cal distinct laminae (Basbaum and Jessell, 2000) (Figure 1). For 
example, Aδ nociceptors project to lamina I as well as to deeper 
dorsal horn (lamina V). The low threshold, rapidly conducting Aβ 
afferents, which respond to light touch, project to deep laminae 
(III, IV, and V). By contrast, C nociceptors project more superfi-
cially to laminae I and II.
This remarkable stratification of afferent subtypes within 
the superficial dorsal horn is further highlighted by the distinct 
projection patterns and circuits engaged by C nociceptors 
(Snider and McMahon, 1998; Braz et al., 2005). For example, 
most peptidergic C fibers terminate within lamina I and the 
most dorsal part of lamina II. By contrast, the nonpeptidergic 
afferents, including the Mrg-expressing subset, terminate in 
the mid-region of lamina II. The most ventral part of lamina II is 
characterized by the presence of excitatory interneurons that 
express the gamma isoform of protein kinase C (PKC), which 
has been implicated in injury-induced persistent pain (Malm-
berg et al., 1997). Recent studies indicate that this PKCγ layer 
is targeted predominantly by myelinated nonnociceptive affer-
ents (Neumann et al., 2008). Consistent with these anatomical 
studies, electrophysiological analyses demonstrate that spinal 
cord neurons within lamina I are generally responsive to nox-
ious stimulation (via Aδ and C fibers), neurons in laminae III 
and IV are primarily responsive to innocuous stimulation (via 
Aβ), and neurons in lamina V receive a convergent nonnoxious 
and noxious input via direct (monosynaptic) Aδ and Aβ inputs 
and indirect (polysynaptic) C fiber inputs. The latter are called 
wide dynamic range (WDR) neurons, in that they respond to a 
broad range of stimulus intensities. There is also commonly a 
visceral input to these WDR neurons, such that the resultant 
convergence of somatic and visceral inputs likely contributes 
to the phenomenon of referred pain, whereby pain secondary 
to an injury affecting a visceral tissue (for example, the heart 
in angina) is referred to a somatic structure (for example, the 
shoulder).
Ascending Pathways and the Supraspinal Processing 
of Pain
Projection neurons within laminae I and V constitute the major 
output from the dorsal horn to the brain (Basbaum and Jessell, 
2000). These neurons are at the origin of multiple ascending 
pathways, including the spinothalamic and spinoreticulotha-
lamic tracts, which carry pain messages to the thalamus and 
brainstem, respectively (Figure 2). The former is particularly 
relevant to the sensory-discriminative aspects of the pain 
experience (that is, where is the stimulus and how intense is 
it?), whereas the latter may be more relevant to poorly local-
ized pains. More recently, attention has focused on spinal cord 
projections to the parabrachial region of the dorsolateral pons, 
because the output of this region provides for a very rapid con-
nection with the amygdala, a region generally considered to pro-
cess information relevant to the aversive properties of the pain 
experience.From these brainstem and thalamic loci, information reaches 
cortical structures. There is no single brain area essential for 
pain (Apkarian et al., 2005). Rather, pain results from activation 
of a distributed group of structures, some of which are more 
associated with the sensory-discriminative properties (such 
as the somatosensory cortex) and others with the emotional 
aspects (such as the anterior cingulate gyrus and insular cor-
tex). More recently, imaging studies demonstrate activation 
of prefrontal cortical areas, as well as regions not generally 
associated with pain processing (such as the basal ganglia 
and cerebellum). Whether and to what extent activation of 
these regions is more related to the response of the individual 
to the stimulus, or to the perception of the pain is not clear. 
Finally, Figure 2 illustrates the powerful descending controls 
that influence (both positive and negatively) the transmission 
of pain messages at the level of the spinal cord.
Acute Pain
The primary afferent nerve fiber detects environmen-
tal stimuli (of a thermal, mechanical, or chemical nature) 
and transduces this information into the language of 
the nervous system, namely electrical current. First, we 
review progress in understanding the molecular basis 
Figure 2. Anatomy of the Pain Pathway
Primary afferent nociceptors convey noxious information to projection neurons 
within the dorsal horn of the spinal cord. A subset of these projection neurons 
transmits information to the somatosensory cortex via the thalamus, providing in-
formation about the location and intensity of the painful stimulus. Other projection 
neurons engage the cingulate and insular cortices via connections in the brain-
stem (parabrachial nucleus) and amygdala, contributing to the affective compo-
nent of the pain experience. This ascending information also accesses neurons of 
the rostral ventral medulla and midbrain periaqueductal gray to engage descend-
ing feedback systems that regulate the output from the spinal cord.Cell 139, October 16, 2009 ©2009 Elsevier Inc. 269
of signal detection, and follow this with a brief over-
view of recent genetic studies that highlight the contri-
bution of voltage-gated channels to pain transmission 
(Figure 3).
Activating the Nociceptor: Heat
Human psychophysical studies have shown that there is a clear 
and reproducible demarcation between the perception of innoc-
uous warmth and noxious heat, which enables us to recognize 
and avoid temperatures capable of causing tissue damage. This 
pain threshold, which typically rests around 43°C, parallels the 
heat sensitivity of C and type II Aδ nociceptors described earlier. 
Indeed, cultured neurons from dissociated dorsal root ganglia 
show similar heat sensitivity. The majority display a threshold 
of 43°C, with a smaller cohort activated by more intense heat 
(threshold >50°C) (Cesare and McNaughton, 1996; Kirschstein 
et al., 1997; Leffler et al., 2007; Nagy and Rang, 1999). Molecu-
lar insights into the process of heat sensation came from the 
cloning and functional characterization of the receptor for cap-
saicin, the main pungent ingredient in “hot” chili peppers. Cap-
saicin and related vanilloid compounds produce burning pain by 
depolarizing specific subsets of C and Aδ nociceptors through 
activation of the capsaicin (or vanilloid) receptor, TRPV1, one 
of approximately 30 members of the greater transient recep-
Figure 3. Nociceptor Diversity
There are a variety of nociceptor subtypes that express unique repertoires 
of transduction molecules and detect one or more stimulus modalities. 
For example, heat-sensitive afferents express TRPV1 and possibly other, 
as yet unidentified heat sensors; the majority of cold-sensitive afferents 
express TRPM8, whereas a small subset likely express an unidentified cold 
sensor. Polymodal nociceptors also express chemoreceptors (e.g. TRPA1) 
and one or more as yet unidentified mechanotransduction channels. These 
fibers also express a host of sodium channels (such as NaV 1.8 and 1.9) 
and potassium channels (such as TRAAK and TREK-1) that modulate 
nociceptor excitability and/or contribute to action potential propagation. 
Three major C fiber nociceptor subsets are shown here, but the extent of 
functional and molecular diversity is undoubtedly more complex. Further-
more, the contribution of each subtype to behavior is a matter of ongoing 
study.270 Cell 139, October 16, 2009 ©2009 Elsevier Inc.tor potential (TRP) ion channel family (Caterina et al., 1997). The 
cloned TRPV1 channel is also gated by increases in ambient 
temperature, with a thermal activation threshold of ?43°C.
Several lines of evidence support the hypothesis that TRPV1 
is an endogenous transducer of noxious heat. First, TRPV1 
is expressed in the majority of heat-sensitive nociceptors 
(Caterina et al., 1997). Second, capsaicin- and heat-evoked 
currents are similar, if not identical, in regard to their pharma-
cological and biophysical properties, as are those of heterolo-
gously expressed TRPV1 channels. Third, and as described 
in greater detail below, TRPV1-evoked responses are mark-
edly enhanced by proalgesic or proinflammatory agents (such 
as extracellular protons, neurotrophins, or bradykinin), all of 
which produce hypersensitivity to heat in vivo (Tominaga et al., 
1998). Fourth, analysis of mice lacking this ion channel not only 
revealed a complete loss of capsaicin sensitivity, but these 
animals also exhibited significant impairment in their ability 
to detect and respond to noxious heat (Caterina et al., 2000; 
Davis et al., 2000). These studies also demonstrated an essen-
tial role for this channel in the process whereby tissue injury 
and inflammation leads to heat hypersensitivity, reflecting the 
ability of TRPV1 to serve as a molecular integrator of thermal 
and chemical stimuli (Caterina et al., 2000; Davis et al., 2000).
The contribution of TRPV1 to acute heat sensation, how-
ever, has been challenged by data collected from an ex vivo 
preparation in which recordings are obtained from the soma of 
DRG neurons with intact central and peripheral fibers. In one 
study, no differences were observed in heat-evoked responses 
from wild-type and TRPV1-deficient animals (Woodbury et al., 
2004), but a more recent analysis from this group found that 
TRPV1-deficient mice do indeed lack a cohort of neurons 
robustly activated by noxious heat (Lawson et al., 2008). Tak-
ing these data together with the results described above, we 
conclude that TRPV1 unquestionably contributes to acute heat 
sensation, but agree that TRPV1 is not solely responsible for 
heat transduction.
In this regard, whereas TRPV1-deficient mice lack a compo-
nent of behavioral heat sensitivity, the use of high-dose cap-
saicin to ablate the central terminals of TRPV1-expressing pri-
mary afferent fibers results in a more profound, if not complete, 
loss of acute heat pain sensitivity (Cavanaugh et al., 2009). 
As for the TRPV1 mutant, there is also a loss of tissue injury-
evoked heat hyperalgesia. Taken together, these results indi-
cate that both the TRPV1-dependent and TRPV1-independent 
component of noxious heat sensitivity is mediated via TRPV1-
expressing nociceptors.
What accounts for the TRPV1-independent component of 
heat sensation? A number of other TRPV channel subtypes, 
including TRPV2, 3, and 4, have emerged as candidate heat 
transducers that could potentially cover detection of stimu-
lus intensities flanking that of TRPV1, including both very hot 
(>50°C) and warm (mid-30°C) temperatures (Lumpkin and 
Caterina, 2007). Heterologously expressed TRPV2 chan-
nels display a temperature activation threshold of ?52°C, 
whereas TRPV3 and TRPV4 are activated between 25°C and 
35°C. TRPV2 is expressed in a subpopulation of Aδ neurons 
that respond to high-threshold noxious heat, and its biophysi-
cal properties resemble those of native high-threshold heat-
evoked currents (Leffler et al., 2007; Rau et al., 2007). As yet, 
there are no published reports describing either physiological 
or behavioral tests of TRPV2 knockout mice. On the other hand, 
TRPV3- and TRPV4-deficient mice do display altered thermal 
preference when placed on a surface of graded temperatures, 
suggesting that these channels contribute in some way to 
temperature detection in vivo (Guler et al., 2002). Interestingly, 
both TRPV3 and TRPV4 show substantially greater expres-
sion in keratinocytes and epithelial cells compared to sensory 
neurons, raising the possibility that detection of heat stimuli 
involves a functional interplay between skin and the underlying 
TRPV1-expressing primary afferent fibers (Chung et al., 2003; 
Peier et al., 2002b).
Activating the Nociceptor: Cold
As for capsaicin and TRPV1, natural cooling agents, such as 
menthol and eucalyptol, have been exploited as pharmacologi-
cal probes to identify and characterize cold-sensitive fibers and 
cells (Hensel and Zotterman, 1951; Reid and Flonta, 2001) and 
the molecules that underlie their behavior. Indeed, most cold-
sensitive neurons respond to menthol and display a thermal acti-
vation threshold of ?25°C. TRPM8 is a cold- and menthol-sen-
sitive channel whose physiological characteristics match those 
of native cold currents and TRPM8-deficient mice show a very 
substantial loss of menthol and cold-evoked responses at the cel-
lular or nerve fiber level. Likewise, these animals display severe 
deficits in cold-evoked behavioral responses (Bautista et al., 
2007; Colburn et al., 2007; Dhaka et al., 2007) over a wide range 
of temperatures spanning 30°C to 10°C. As in the case of TRPV1 
and heat, TRPM8-deficient mice are not completely insensitive to 
cold. For example, there remains a small (?4%) cohort of cold-
sensitive, menthol-insensitive neurons that have a low threshold 
of activation, approximately 12°C. These may account for the 
residual cold sensitivity seen in behavioral tests, wherein TRPM8-
deficient animals can still avoid extremely cold surfaces below 
10°C. Importantly, TRPM8-deficient mice show normal sensitiv-
ity to noxious heat. Indeed, TRPV1 and TRPM8 are expressed in 
largely nonoverlapping neuronal populations, consistent with the 
notion that hot and cold detection mechanisms are organized into 
anatomically and functionally distinct peripheral “labeled lines.”
Based on heterologous expression systems, TRPA1 has also 
been suggested to detect cold, specifically within the noxious 
(<15°C) range. Moreover, TRPA1 is activated by the cooling 
compounds icilin and menthol (Bandell et al., 2004; Karashima 
et al., 2007; Story et al., 2003), albeit at relatively high con-
centrations compared to their actions at TRPM8. However, 
there continues to be disagreement as to whether native or 
recombinant TRPA1 is intrinsically cold sensitive (Bandell et 
al., 2004; Jordt et al., 2004; Karashima et al., 2009; Nagata et 
al., 2005; Zurborg et al., 2007). This controversy has not been 
resolved by the analysis of two independent TRPA1-deficient 
mouse lines. At the cellular level, one study showed normal 
cold-evoked responses in TRPA1-deficient neurons after a 
30 s drop in temperature from 22°C to 4°C (Bautista et al., 
2006); a more recent study has shown a decrease in cold-
sensitive neurons from 26% (WT) to 10% (TRPA1−/−), when 
tested after a 200 s drop in temperature, from 30°C to 10°C 
(Karashima et al., 2009). In behavioral studies, TRPA1-deficient 
mice display responses similar to wild-type littermates in the cold-plate and acetone-evoked evaporative cooling assays 
(Bautista et al., 2006). A second study using the same assays 
showed that female, but not male, TRPA1 knockout animals 
displayed attenuated cold sensitivity compared to wild-type 
littermates (Kwan et al., 2006). Karashima et al. found no differ-
ence in shivering or paw withdrawal latencies in male or female 
TRPA1-deficient mice on the cold plate test, but observed that 
prolonged exposure to the cold surface elicited jumping in 
wild-type, but not TRPA1-deficient animals (Karashima et al., 
2009). Conceivably, the latter phenotype reflects a contribution 
of TRPA1 to cold sensitivity in the setting of tissue injury, but 
not to acute cold pain. Consistent with the latter hypothesis, 
single nerve fiber recordings show no decrement in acute cold 
sensitivity in TRPA1-deficient mice (Kwan et al., 2009). Finally, 
it is noteworthy that capsaicin-treated mice lacking the central 
terminals of TRPV1-expressing fibers show intact behavioral 
responses to cool and noxious cold stimuli (Cavanaugh et al., 
2009). Because TRPA1 is expressed in a subset of TRPV1-pos-
itive neurons, it follows that TRPA1 is not required for normal 
acute cold sensitivity. Future studies using mice deficient for 
both TRPM8 and TRPA1 will help to resolve these issues and to 
identify the molecules and cell types that underlie the residual 
TRPM8-independent component of cold sensitivity.
Additional molecules, including voltage-gated sodium 
channels (discussed below), voltage-gated potassium chan-
nels, and two-pore background KCNK potassium channels, 
coordinate with TRPM8 to fine tune cold thresholds or to 
propagate cold-evoked action potentials (Viana et al., 2002; 
Zimmermann et al., 2007; Noel et al., 2009). For example, 
specific Kv1 inhibitors increase the temperature threshold of 
cold-sensitive neurons, and injection of these inhibitors into 
the rodent hindpaw reduces behavioral responses to cold, 
but not to heat or mechanical stimuli (Madrid et al., 2009). Two 
members of the KCNK channel family, KCNK2 (TREK-1) and 
KCNK4 (TRAAK), are expressed in a subset of C fiber nocice-
ptors (Noel et al., 2009) and can be modulated by numerous 
physiological and pharmacological stimuli, including pres-
sure and temperature. Furthermore, mice lacking these chan-
nels display abnormalities in sensitivity to pressure, heat, and 
cold (Noel et al., 2009). Although these findings suggest that 
TREK-1 and TRAAK channels modulate nociceptor excitabil-
ity, it remains unclear how their intrinsic sensitivity to physi-
cal stimuli relates to their in vivo contribution to thermal or 
mechanical transduction.
Activating the Nociceptor: Mechanical Stimuli
The somatosensory system detects quantitatively and quali-
tatively diverse mechanical stimuli, ranging from light brush of 
the skin to distension of the bladder wall. A variety of mecha-
nosensitive neuronal subtypes are specialized to detect this 
diverse array of mechanical stimuli and can be categorized 
according to threshold sensitivity. High-threshold mechanore-
ceptors include C fibers and slowly adapting Aδ mechanore-
ceptor (AM) fibers, both of which terminate as free nerve end-
ings in the skin. Low-threshold mechanoreceptors include Aδ 
D hair fibers that terminate on down hairs in the skin and detect 
light touch. Finally, Aβ fibers that innervate Merkel cells, Pacin-
ian corpuscles, and hair follicles detect texture, vibration, and 
light pressure.Cell 139, October 16, 2009 ©2009 Elsevier Inc. 271
As in the case of thermal stimuli, mechanical sensitivity has 
been probed at a number of levels, including dissociated sen-
sory neurons in culture and ex vivo fiber recordings, as well as 
recordings from central (i.e., dorsal horn neurons) and mea-
surements of behavioral output. Ex vivo skin-nerve recordings 
have been most informative in matching stimulus properties 
(such as intensity, frequency, speed, and adaptation) to spe-
cific fiber subtypes. For example, Aβ fibers are primarily asso-
ciated with sensitivity to light touch, whereas C and Aδ fibers 
are primarily responsive to noxious mechanical insults. At the 
behavioral level, mechanical sensitivity is typically assessed 
using two techniques. The most common involves measur-
ing reflex responses to constant force applied to the rodent 
hind paw by calibrated filaments (Von Frey hairs). The second 
applies increasing pressure to the paw or tail via a clamp sys-
tem. In either case, information about mechanical thresholds is 
obtained under normal (acute) or injury (hypersensitivity) situ-
ations. One of the challenges in this area has been to develop 
additional behavioral assays that measure different aspects of 
mechanosensation, such as texture discrimination and vibra-
tion, that will facilitate the study of both noxious and nonnox-
ious touch (Wetzel et al., 2007).
At the cellular level, pressure can be applied to the cell bod-
ies of cultured somatosensory neurons (or to their neurites) 
using a glass probe, changes in osmotic strength, or stretch 
via distension of an elastic culture surface, though it is unclear 
which stimulus best mimics physiological pressure (Bhat-
tacharya et al., 2008; Cho et al., 2002, 2006; Drew et al., 2002; 
Hu and Lewin, 2006; Lin et al., 2009; Takahashi and Gotoh, 
2000). Responses can be assessed using electrophysiological 
or live-cell imaging methods. The consensus from such stud-
ies is that pressure opens a mechanosensitive cation chan-
nel to elicit rapid depolarization. However, a dearth of specific 
pharmacological probes and molecular markers with which to 
characterize these responses or to label relevant neuronal sub-
types has hampered attempts to match cellular activities with 
anatomically or functionally defined nerve fiber subclasses. 
These limitations have also impeded the molecular analysis 
of mechanosensation and the identification of molecules that 
constitute the mechanotransduction machinery. Nonetheless, 
a number of candidates have emerged, based largely on stud-
ies of mechanosensation in model genetic organisms. Mam-
malian orthologs of these proteins have been examined using 
gene targeting approaches in mice, in which the techniques 
mentioned above can be used to assess deficits in mecha-
nosensation at all levels. Below, we briefly summarize some of 
the candidates revealed in these studies.
Candidate Mechanotransducers: DEG/ENaC Channels
Studies in the nematode Caenorhabditis elegans (C. elegans) 
have identified mec-4 and mec-10, members of the degenerin/
epithelial Na+ channel (DEG/ENaC) families, as mechanotrans-
ducers in body touch neurons (Chalfie, 2009). On the basis of 
these studies, the mammalian orthologs ASIC 1, 2, and 3 have 
been proposed as mechanotransduction channels. ASICs are 
acid-sensitive ion channels that serve as receptors for extra-
cellular protons (tissue acidosis) produced during ischemia 
(see below). Although these channels are expressed by both 
low- and high-threshold mechanosensitive neurons, genetic 272 Cell 139, October 16, 2009 ©2009 Elsevier Inc.studies do not uniformly support an essential role in mechan-
otransduction. Mice lacking functional ASIC1 channels display 
normal behavioral responses to cutaneous touch and little or 
no change in mechanical sensitivity when assessed by single 
fiber recording (Page et al., 2004; Price et al., 2000). Likewise, 
peripheral nerve fibers from ASIC2-deficient mice display only 
a slight decrease in action potential firing to mechanical stim-
uli, whereas ASIC3-deficient fibers display a slight increase 
(no change in mechanical thresholds or baseline behavioral 
mechanical sensitivity was observed in these animals) (Price et 
al., 2001; Roza et al., 2004). Analysis of mice deficient for both 
ASIC2 and ASIC3 also fails to support a role for these chan-
nels in cutaneous mechanotransduction (Drew et al., 2004). 
Thus, although these channels appear to play a role in muscu-
loskeletal and ischemic pain (see below), their contribution to 
mechanosensation remains unresolved.
Genetic studies suggest that C. elegans mec-4/mec-10 chan-
nels exist in a complex with the stomatin-like protein MEC-2 
(Chalfie, 2009). Mice lacking the MEC-2 ortholog, SLP3, display 
a loss of mechanosensitivity in low-threshold Aβ and Aδ fibers, 
but not in C fibers (Wetzel et al., 2007). These mice exhibit 
altered tactile acuity but display normal responses to noxious 
pressure, suggesting that SLP3 contributes to the detection of 
innocuous, but not noxious, mechanical stimuli. Whether SLP3 
functions in a mechanotransduction complex or interacts with 
ASICs in mammalian sensory neurons is unknown.
Candidate Mechanotransducers: TRP Channels
When expressed heterologously, TRPV2 not only responds to 
noxious heat, but also to osmotic stretch. Additionally, native 
TRPV2 channels in vascular smooth muscle cells are activated 
by direct suction and osmotic stimuli (Muraki et al., 2003). A 
role for TRPV2 for somatosensory mechanotransduction in 
vivo has not yet been tested.
TRPV2 is robustly expressed in medium- and large-diam-
eter Aδ fibers that respond to both mechanical and thermal 
stimuli (Caterina et al., 1999; Muraki et al., 2003). TRPV4 shows 
modest expression in sensory ganglia, but is more abundantly 
expressed in the kidney and stretch-sensitive urothelial cells of 
the bladder (Gevaert et al., 2007; Mochizuki et al., 2009). When 
heterologously expressed, both TRPV2 and TRPV4 have been 
shown to respond to changes in osmotic pressure (Guler et al., 
2002; Liedtke et al., 2000; Mochizuki et al., 2009; Strotmann 
et al., 2000). Analysis of TRPV4-deficient animals suggests a 
role in osmosensation as knockout animals display defects in 
blood pressure, water balance, and bladder voiding (Gevaert et 
al., 2007; Liedtke and Friedman, 2003). These animals exhibit 
normal acute cutaneous mechanosensation, but show deficits 
in models of mechanical and thermal hyperalgesia (Alessandri-
Haber et al., 2006; Chen et al., 2007; Grant et al., 2007; Suzuki 
et al., 2003). Thus, TRPV4 is unlikely to serve as a primary 
mechanotransducer in sensory neurons but may contribute to 
injury-evoked pain hypersensitivity.
TRPA1 has also been proposed to serve as a detector of 
mechanical stimuli. Heterologously expressed mammalian 
TRPA1 is activated by membrane crenators (Hill and Schaefer, 
2007), and the worm ortholog is sensitive to mechanical pres-
sure applied via a suction pipette (Kindt et al., 2007). However, 
TRPA1-deficient mice display only weak defects in mecha-
nosensory behavior, and the results are inconsistent. Two stud-
ies reported no change in mechanical thresholds in TRPA1-defi-
cient animals (Bautista et al., 2006; Petrus et al., 2007), whereas 
a third study reported deficits (Kwan et al., 2006). A more recent 
study shows that C and Aβ mechanosensitive fibers in TRPA1 
knockout animals have altered responses to mechanical stim-
ulation (some increased and others decreased) (Kwan et al., 
2009). Whether and how these differential physiological effects 
are manifest at the level of behavior is unclear. Taken together, 
these data indicate that TRPA1 does not appear to function as 
a primary detector of acute mechanical stimuli, but perhaps 
modulates excitability of mechanosensitive afferents.
Candidate Mechanotransducers: KCNK Channels
In addition to the potential mechanotransducer role of KCNK2 
and 4 (see above), KCNK18 has been discussed for its possible 
contribution to mechanosensation. Thus, KCNK18 is targeted 
by hydroxy-a-sanshool, the pungent ingredient in Szechuan 
peppercorns that produces tingling and numbing sensations, 
suggestive of an interaction with touch-sensitive neurons (Bau-
tista et al., 2008; Bryant and Mezine, 1999; Sugai et al., 2005). 
KCNK18 is expressed in a subset of presumptive peptidergic 
C fibers and low threshold (Aβ) mechanoreceptors, where it 
serves as a major regulator of action potential duration and 
excitability (Bautista et al., 2008; Dobler et al., 2007). Moreover, 
sanshool depolarizes osmo- and mechanosensitive large-
diameter sensory neurons, as well as a subset of nociceptors 
(Bautista et al., 2008; Bhattacharya et al., 2008). Although it is 
not known whether KCNK18 is directly sensitive to mechanical 
stimulation, it may be a critical regulator of the excitability of 
neurons involved in innocuous or noxious touch sensation.
In summary, the molecular basis of mammalian mechan-
otransduction is far from clarified. Mechanical hypersensitivity 
in response to tissue or nerve injury represents a major clini-
cal problem, and thus elucidating the biological basis of touch 
under normal and pathophysiological conditions remains one 
of the main challenges in somatosensory and pain research.
Activating the Nociceptor: Chemical
Chemo-nociception is the process by which primary afferent 
neurons detect environmental irritants and endogenous factors 
produced by physiological stress. In the context of acute pain, 
chemo-nociceptive mechanisms trigger aversive responses to 
a variety of environmental irritants. Here, again, TRP channels 
have prominent roles, which is perhaps not surprising given that 
they function as receptors for plant-derived irritants, including 
capsaicin (TRPV1), menthol (TRPM8), and the pungent ingredi-
ents in mustard and garlic plants, isothiocyanates, and thiosul-
finates (TRPA1) (Bandell et al., 2004; Caterina et al., 1997; Jordt 
et al., 2004; McKemy et al., 2002; Peier et al., 2002a).
With respect to environmental irritants, TRPA1 has emerged 
as a particularly interesting member of this group. This is 
because TRPA1 responds to compounds that are structurally 
diverse but unified in their ability to form covalent adducts with 
thiol groups. For example, allyl isothiocyanate (from wasabi) 
or allicin (from garlic) are membrane permeable electrophiles 
that activate TRPA1 by covalently modifying cysteine residues 
within the amino-terminal cytoplasmic domain of the chan-
nel (Hinman et al., 2006; Macpherson et al., 2007). How this 
promotes channel gating is currently unknown. Nevertheless, simply establishing the importance of thiol reactivity in this 
process has implicated TRPA1 as a key physiological target 
for a wide and chemically diverse group of environmental toxi-
cants. One notable example is acrolein (2-propenal), a highly 
reactive a,β-unsaturated aldehyde present in tear gas, vehicle 
exhaust, or smoke from burning vegetation (i.e., forest fires 
and cigarettes). Acrolein and other volatile irritants (such as 
hypochlorite, hydrogen peroxide, formalin, and isocyanates) 
activate sensory neurons that innervate the eyes and airways, 
producing pain and inflammation (Bautista et al., 2006; Bessac 
and Jordt, 2008; Caceres et al., 2009). This action can have 
especially dire consequences for those suffering from asthma, 
chronic cough, or other pulmonary disorders. Mice lacking 
TRPA1 show greatly reduced sensitivity to such agents, under-
scoring the critical nature of this channel as a sensory detec-
tor of reactive environmental irritants (Caceres et al., 2009). In 
addition to these environmental toxins, TRPA1 is targeted by 
some general anesthetics (such as isofluorane) or metabolic 
byproducts of chemotherapeutic agents (such as cyclophos-
phamide), which likely underlies some of the adverse side 
effects of these drugs, including acute pain and robust neu-
roinflammation (Bautista et al., 2006; Matta et al., 2008).
Finally, chemical irritants and other proalgesic agents are 
also produced endogenously in response to tissue damage 
or physiological stress, including oxidative stress. Such fac-
tors can act alone, or in combination, to sensitize nociceptors 
to thermal and/or mechanical stimuli, thereby lowering pain 
thresholds. The result of this action is to enhance guarding 
and protective reflexes in the aftermath of injury. Thus, chemo-
nociception represents an important interface between acute 
and persistent pain, especially in the context of peripheral 
tissue injury and inflammation, as discussed in greater detail 
below.
Acute Pain: Conducting the Pain Signal
Once thermal and mechanical signals are transduced by the 
primary afferent terminal, the receptor potential activates a 
variety of voltage-gated ion channels. Voltage-gated sodium 
and potassium channels are critical to the generation of action 
potentials that convey nociceptor signals to synapses in the 
dorsal horn. Voltage-gated calcium channels play a key role in 
neurotransmitter release from central or peripheral nociceptor 
terminals to generate pain or neurogenic inflammation, respec-
tively. We restrict our discussion to members of the sodium 
and calcium channel families that serve as targets of currently 
used analgesic drugs, or for which human genetics support a 
role in pain transmission. A recent review has discussed the 
important contribution of KCNQ potassium channels, including 
the therapeutic benefit of increasing K+ channel activity for the 
treatment of persistent pain (Brown and Passmore, 2009).
Voltage-Gated Sodium Channels
A variety of sodium channels are expressed in somatosen-
sory neurons, including the tetrodotoxin (TTX)-sensitive 
channels Nav1.1, 1.6, and 1.7 and the TTX-resistant chan-
nels Nav1.8 and 1.9. In recent years, the contribution of 
Nav1.7 has received much attention, as altered activity of 
this channel leads to a variety of human pain disorders (Cox 
et al., 2006; Dib-Hajj et al., 2008). Patients with loss-of-func-Cell 139, October 16, 2009 ©2009 Elsevier Inc. 273
Figure 4. Peripheral Mediators of 
 Inflammation
Tissue damage leads to the release of inflamma-
tory mediators by activated nociceptors or non-
neural cells that reside within or infiltrate into the 
injured area, including mast cells, basophils, plate-
lets, macrophages, neutrophils, endothelial cells, 
keratinocytes, and fibroblasts. This “inflammatory 
soup” of signaling molecules includes serotonin, 
histamine, glutamate, ATP, adenosine, substance 
P, calcitonin-gene related peptide (CGRP), brady-
kinin, eicosinoids prostaglandins, thromboxanes, 
leukotrienes, endocannabinoids, nerve growth 
factor (NGF), tumor necrosis factor a (TNF-a), 
interleukin-1β (IL-1β), extracellular proteases, 
and protons. These factors act directly on the 
nociceptor by binding to one or more cell surface 
receptors, including G protein-coupled receptors 
(GPCR), TRP channels, acid-sensitive ion chan-
nels (ASIC), two-pore potassium channels (K2P), 
and receptor tyrosine kinases (RTK), as depicted 
on the peripheral nociceptor terminal. Adapted 
from Meyer et al. (2008).tion mutations within this gene are unable to detect noxious 
stimuli, and as a result suffer injuries due to lack of protec-
tive reflexes. In contrast, a number of gain-of-function muta-
tions in Nav1.7 leads to hyperexcitability of the channel and 
are associated with two distinct pain disorders in humans, 
erythromelalgia and paroxysmal extreme pain disorder, both 
of which cause intense burning sensations (Estacion et al., 
2008; Fertleman et al., 2006; Yang et al., 2004). Animal stud-
ies have demonstrated that Nav1.7 is highly upregulated in 
a variety of inflammatory pain models. Indeed, analysis of 
mice lacking Nav1.7 in C nociceptors supports a key role for 
this channel in mechanical and thermal hypersensitivity after 
inflammation, and in acute responses to noxious mechani-
cal stimuli (Nassar et al., 2004). Somewhat surprisingly, pain 
induced by nerve injury is unaltered, suggesting that distinct 
sodium channel subtypes, or another population of Nav1.7-
expressing afferents, contribute to neuropathic pain (Nassar 
et al., 2005).
The Nav1.8 sodium channel is also highly expressed by most 
C nociceptors. As with Nav1.7 knockout animals, those lack-
ing Nav1.8 display modest deficits in sensitivity to innocuous 
or noxious heat, or innocuous pressure; however, they display 
attenuated responses to noxious mechanical stimuli (Akopian 
et al., 1999). Nav1.8 is also required for the transmission of cold 
stimuli, as mice lacking this channel are insensitive to cold over 
a wide range of temperatures (Zimmermann et al., 2007). This 
is because Nav1.8 is unique among voltage-sensitive sodium 
channels in that it does not inactivate at low temperature, mak-
ing it the predominant action potential generator under cold 
conditions.
Interestingly, transgenic mice lacking the Nav1.8-express-
ing subset of sensory neurons, which were deleted by tar-
geted expression of diphtheria toxin A (Abrahamsen et al., 
2008), display attenuated responses to both low- and high-
threshold mechanical stimuli and cold. In addition, mechani-
cal and thermal hypersensitivity in inflammatory pain mod-
els are severely attenuated. The differential phenotypes of 274 Cell 139, October 16, 2009 ©2009 Elsevier Inc.mice lacking Nav1.8 channels versus deletion of the Nav1.8-
expressing neurons presumably reflect the contribution of 
other proteins to the transmission of pain messages.
Voltage-gated sodium channels are targets of local anes-
thetic drugs, highlighting the potential for the development of 
subtype-specific analgesics. Nav1.7 is a particularly interest-
ing target for treating inflammatory pain syndromes, in part 
because the human genetic studies suggest that Nav1.7 inhibi-
tors should reduce pain without altering other essential physio-
logical processes (see above). Another potential application of 
sodium channel blockers may be to treat extreme hypersensi-
tivity to cold, a particularly troublesome adverse side effect of 
platinum-based chemotherapeutics, such as oxaliplatin (Attal 
et al., 2009). Nav1.8 (or TRPM8) antagonists may alleviate this, 
or other forms of cold allodynia. Finally, the great utility of the 
antidepressant serotonin and norepinephrine reuptake inhibi-
tors for the treatment of neuropathic pain may, in fact, result 
from their ability to block voltage gated sodium channels (Dick 
et al., 2007).
Voltage-Gated Calcium Channels
A variety of voltage-gated calcium channels are expressed 
in nociceptors. N-, P/Q-, and T-type calcium channels have 
received the most attention. P/Q-type channels are expressed 
at synaptic terminals in laminae II–IV of the dorsal horn. Their 
exact role in nociception is not completely resolved. However, 
mutations in these channels have been linked to familial hemi-
plegic migraine (de Vries et al., 2009). N- and T-type calcium 
channels are also expressed by C fibers and are upregulated 
under pathophysiological states, as in models of diabetic neu-
ropathy or after other forms of nerve injury. Animals lacking 
Cav2.2 or 3.2 show reduced sensitization to mechanical or 
thermal stimuli after inflammation or nerve injury, respectively 
(Cao, 2006; Swayne and Bourinet, 2008; Zamponi et al., 2009; 
Messinger et al., 2009). Moreover, ω-conotoxin GVIA, which 
blocks N-type channels, is administered intrathecally (as 
ziconotide) to provide relief for intractable cancer pain (Rauck 
et al., 2009).
All calcium channels are heteromeric proteins composed of 
a1 pore forming subunits and the modulatory subunits a2δ, 
a2β, or a2γ. The a2δ subunit regulates current density and 
kinetics of activation and inactivation. In C nociceptors, the 
a2δ subunit is dramatically upregulated after nerve injury and 
plays a key role in injury-evoked hypersensitivity and allodynia 
(Luo et al., 2001). Indeed, this subunit is the target of the gaba-
pentinoid class of anticonvulsants, which are now widely used 
to treat neuropathic pain (Davies et al., 2007).
Persistent Pain: Peripheral Mechanisms
Persistent pain associated with injury or diseases (such as 
diabetes, arthritis, or tumor growth) can result from altera-
tions in the properties of peripheral nerves. This can occur as a 
consequence of damage to nerve fibers, leading to increased 
spontaneous firing or alterations in their conduction or neu-
rotransmitter properties. In fact, the utility of topical and even 
systemic local anesthetics for the treatment of different neuro-
pathic pain conditions (such as postherpetic neuralgia) likely 
reflects their action on sodium channels that accumulate in 
injured nerve fibers.
The Chemical Milieu of Inflammation
Peripheral sensitization more commonly results from inflam-
mation-associated changes in the chemical environment of 
the nerve fiber (McMahon et al., 2008). Thus, tissue damage is 
often accompanied by the accumulation of endogenous fac-
tors released from activated nociceptors or nonneural cells 
that reside within or infiltrate into the injured area (including 
mast cells, basophils, platelets, macrophages, neutrophils, 
endothelial cells, keratinocytes, and fibroblasts). Collectively, 
these factors, referred to as the “inflammatory soup,” repre-
sent a wide array of signaling molecules, including neurotrans-
mitters, peptides (substance P, CGRP, bradykinin), eicosinoids 
and related lipids (prostaglandins, thromboxanes, leukotrienes, 
endocannabinoids), neurotrophins, cytokines, and chemok-
ines, as well as extracellular proteases and protons. Remark-
ably, nociceptors express one or more cell-surface receptors 
capable of recognizing and responding to each of these proin-
flammatory or proalgesic agents (Figure 4). Such interactions 
enhance excitability of the nerve fiber, thereby heightening its 
sensitivity to temperature or touch.
Unquestionably, the most common approach to reducing 
inflammatory pain involves inhibiting the synthesis or accumu-
lation of components of the inflammatory soup. This is best 
exemplified by nonsteroidal anti-inflammatory drugs, such 
as aspirin or ibuprofen, which reduce inflammatory pain and 
hyperalgesia by inhibiting cyclooxygenases (Cox-1 and Cox-2) 
involved in prostaglandin synthesis. A second approach is to 
block the actions of inflammatory agents at the nociceptor. 
Here, we highlight examples that provide new insight into cel-
lular mechanisms of peripheral sensitization or that form the 
basis of new therapeutic strategies for treating inflammatory 
pain.
NGF is perhaps best known for its role as a neurotrophic fac-
tor required for survival and development of sensory neurons 
during embryogenesis, but in the adult, NGF is also produced 
in the setting of tissue injury and constitutes an important com-
ponent of the inflammatory soup (Ritner et al., 2009). Among its many cellular targets, NGF acts directly on peptidergic C 
fiber nociceptors, which express the high-affinity NGF recep-
tor tyrosine kinase, TrkA, as well as the low-affinity neurotro-
phin receptor, p75 (Chao, 2003; Snider and McMahon, 1998). 
NGF produces profound hypersensitivity to heat and mechani-
cal stimuli through two temporally distinct mechanisms. At 
first, a NGF-TrkA interaction activates downstream signaling 
pathways, including phospholipase C (PLC), mitogen-activated 
protein kinase (MAPK), and phosphoinositide 3-kinase (PI3K). 
This results in functional potentiation of target proteins at the 
peripheral nociceptor terminal, most notably TRPV1, leading 
to a rapid change in cellular and behavioral heat sensitivity 
(Chuang et al., 2001). In addition to these rapid actions, NGF 
is also retrogradely transported to the nucleus of the nocicep-
tor, where it promotes increased expression of pronociceptive 
proteins, including substance P, TRPV1, and the Nav1.8 volt-
age-gated sodium channel subunit (Chao, 2003; Ji et al., 2002). 
Together, these changes in gene expression enhance excitabil-
ity of the nociceptor and amplify the neurogenic inflammatory 
response.
In addition to neurotrophins, injury promotes the release of 
numerous cytokines, chief among them interleukin-1β (IL-1β) 
and IL-6, and tumor necrosis factor a (TNF-a) (Ritner et al., 
2009). Although there is evidence to support a direct action of 
these cytokines on nociceptors, their primary contribution to 
pain hypersensitivity results from potentiation of the inflamma-
tory response and increased production of proalgesic agents 
(such as prostaglandins, NGF, bradykinin, and extracellular 
protons).
Irrespective of their pronociceptive mechanisms, interfer-
ing with neurotrophin or cytokine signaling has become a 
major strategy for controlling inflammatory disease or result-
ing pain. The main approach involves blocking NGF or TNF-a 
action with a neutralizing antibody. In the case of TNF-a, this 
has been remarkably effective in the treatment of numerous 
autoimmune diseases, including rheumatoid arthritis, leading 
to dramatic reduction in both tissue destruction and accom-
panying hyperalgesia (Atzeni et al., 2005). Because the main 
actions of NGF on the adult nociceptor occur in the setting of 
inflammation, the advantage of this approach is that hyperal-
gesia will decrease without affecting normal pain perception. 
Indeed, anti-NGF antibodies are currently in clinical trials for 
treatment of inflammatory pain syndromes (Hefti et al., 2006).
Targets of the Inflammatory Soup
TRPV1. Robust hypersensitivity to heat can develop with 
inflammation or after injection of specific components of the 
inflammatory soup (such as bradykinin or NGF). Lack of such 
sensitization in TRPV1-deficient mice provides genetic support 
for the idea that TRPV1 is a key component of the mechanism 
through which inflammation produces thermal hyperalgesia 
(Caterina et al., 2000; Davis et al., 2000). Indeed, in vitro studies 
have shown that TRPV1 functions as a polymodal signal inte-
grator whose thermal sensitivity can be profoundly modulated 
by components of the inflammatory soup (Tominaga et al., 
1998). Some of these inflammatory agents (for example, extra-
cellular protons and lipids) function as direct positive allosteric 
modulators of the channel, whereas others (bradykinin, ATP, 
and NGF) bind to their own receptors on primary afferents and Cell 139, October 16, 2009 ©2009 Elsevier Inc. 275
Figure 5. Central Sensitization
(1) Glutamate/NMDA receptor-mediated sensi-
tization. After intense stimulation or persistent 
injury, activated C and Aδ nociceptors release a 
variety of neurotransmitters, including glutamate, 
substance P, calcitonin-gene related peptide 
(CGRP), and ATP, onto output neurons in lamina 
I of the superficial dorsal horn (red). As a con-
sequence, normally silent NMDA glutamate re-
ceptors located in the postsynaptic neuron can 
now signal, increase intracellular calcium, and 
activate a host of calcium-dependent signaling 
pathways and second messengers including 
mitogen-activated protein kinase (MAPK), protein 
kinase C (PKC), protein kinase A (PKA), phos-
phatidylinositol 3-kinase (PI3K), and Src. This 
cascade of events will increase the excitability of 
the output neuron and facilitate the transmission 
of pain messages to the brain.
(2) Disinhibition. Under normal circumstances, in-
hibitory interneurons (blue) continuously release 
GABA and/or glycine (Gly) to decrease the excitability of lamina I output neurons and modulate pain transmission (inhibitory tone). However, in the setting of 
injury, this inhibition can be lost, resulting in hyperalgesia. Additionally, disinhibition can enable nonnociceptive myelinated Aβ primary afferents to engage the 
pain transmission circuitry such that normally innocuous stimuli are now perceived as painful. This occurs, in part, through the disinhibition of excitatory PKCγ 
expressing interneurons in inner lamina II.
(3) Microglial activation. Peripheral nerve injury promotes release of ATP and the chemokine fractalkine that will stimulate microglial cells. In particular, activation 
of purinergic P2-R receptors, CX3CR1, and Toll-like receptors on microglia (purple) results in the release of brain-derived neurotrophic factor (BDNF), which 
through activation of TrkB receptors expressed by lamina I output neurons, promotes increased excitability and enhanced pain in response to both noxious 
and innocuous stimulation (that is, hyperalgesia and allodynia). Activated microglia also release a host of cytokines, such as tumor necrosis factor a (TNFa), 
interleukin-1β and 6 (IL-1β, IL-6), and other factors that contribute to central sensitization.modulate TRPV1 through activation of downstream intracellular 
signaling pathways. In either case, these interactions result in a 
profound decrease in the channel’s thermal activation thresh-
old, as well as an increase in the magnitude of responses at 
suprathreshold temperatures—the biophysical equivalents of 
allodynia and hyperalgesia, respectively.
However, there remains controversy concerning the intracel-
lular signaling mechanisms most responsible for TRPV1 modu-
lation (Lumpkin and Caterina, 2007). Reminiscent of ancestral 
TRP channels in the fly eye, many mammalian TRP channels are 
activated or positively modulated by phospholipase C-medi-
ated cleavage of plasma membrane phosphatidyl inositol 4,5 
bisphosphate (PIP2). Of course, there are many downstream 
consequences of this action, including a decrease in membrane 
PIP2, increased levels of diacylglycerol and its metabolites, and 
increased cytoplasmic calcium, as well as consequent activa-
tion of protein kinases. In the case of TRPV1, most, if not all, 
of these pathways have been implicated in the sensitization 
process, and it remains to be seen which are most relevant 
to behavioral thermal hypersensitivity. Nevertheless, there is 
broad agreement that TRPV1 modulation is relevant to tissue 
injury-evoked pain hypersensitivity, particularly in the setting of 
inflammation. This would include conditions such as sunburn, 
infection, rheumatoid or osteoarthritis, and inflammatory bowel 
disease. Another interesting example includes pain from bone 
cancer (Honore et al., 2009), where tumor growth and bone 
destruction are accompanied by extremely robust tissue aci-
dosis, as well as production of cytokines, neurotrophins, and 
prostaglandins.
TRPA1. As described above, TRPA1 is activated by com-
pounds that form covalent adducts with cysteine residues. In 
addition to environmental toxins, this includes endogenous 
thiol reactive electrophiles that are produced during tissue 
injury and inflammation, or as a consequence of oxidative or 276 Cell 139, October 16, 2009 ©2009 Elsevier Inc.nitrative stress. Chief among such agents are 4-hydroxy-2-
nonenal and 15-deoxy-∆12,14-prostaglandin J2, which are both 
a,β unsaturated aldehydes generated through peroxidation or 
spontaneous dehydration of lipid second messengers (Ander-
sson et al., 2008; Cruz-Orengo et al., 2008; Materazzi et al., 
2008; Trevisani et al., 2007). Other endogenous TRPA1 ago-
nists include nitro oleic acid, hydrogen peroxide, and hydrogen 
sulfide. In addition to these directly acting agents, TRPA1 is 
also modulated indirectly by proalgesic agents, such as bra-
dykinin, which act via PLC-coupled receptors. Indeed, TRPA1-
deficient mice show dramatically reduced cellular and behav-
ioral responses to all of these agents, as well as a reduction 
in tissue injury-evoked thermal and mechanical hypersensitiv-
ity (Bautista et al., 2006; Kwan et al., 2006). Finally, because 
TRPA1 plays a key role in neurogenic and other inflammatory 
responses to both endogenous agents and volatile environ-
mental toxins, its contribution to airway inflammation, such as 
occurs in asthma, is of particular interest. Indeed, genetic or 
pharmacological blockade of TRPA1 reduces airway inflamma-
tion in a rodent model of allergen-evoked asthma (Caceres et 
al., 2009).
ASICs. As noted above, ASIC channels are members of the 
DEG/ENaC family that are activated by acidification and thus 
represent another important site for the action of extracellular 
protons produced as a consequence of tissue injury or meta-
bolic stress. ASIC subtypes can form a variety of homomeric or 
heteromeric channels, each having distinct pH sensitivity and 
expression profile. Channels containing the ASIC3 subtype are 
specifically expressed by nociceptors and especially well rep-
resented in fibers that innervate skeletal and cardiac muscle. 
In these tissues, anaerobic metabolism leads to buildup of lac-
tic acid and protons, which activate nociceptors to generate 
musculoskeletal or cardiac pain (Immke and McCleskey, 2001). 
Interestingly, ASIC3-containing channels open in response to 
the modest decrease in pH (e.g., 7.4 to 7.0) that occurs with 
cardiac ischemia (Yagi et al., 2006). Lactic acid also signifi-
cantly potentiates proton-evoked gating through a mechanism 
involving calcium chelation (Immke and McCleskey, 2003). 
Thus, ASIC3-containing channels detect and integrate signals 
specifically associated with muscle ischemia and, in this way, 
are functionally distinct from other acid sensors on the primary 
afferent, such as TRPV1 or other ASIC channel subtypes.
Persistent Pain: Central Mechanisms
Central sensitization refers to the process through which a 
state of hyperexcitability is established in the central nervous 
system, leading to enhanced processing of nociceptive (pain) 
messages (Woolf, 1983). Although numerous mechanisms 
have been implicated in central sensitization, here we focus 
on three: alteration in glutamatergic neurotransmission/NMDA 
receptor-mediated hypersensitivity, loss of tonic inhibitory con-
trols (disinhibition), and glial-neuronal interactions (Figure 5).
Glutamate/NMDA Receptor-Mediated Sensitization
Acute pain is signaled by the release of glutamate from the cen-
tral terminals of nociceptors, generating excitatory postsynap-
tic currents (EPSCs) in second order dorsal horn neurons. This 
occurs primarily through activation of postsynaptic AMPA and 
kainate subtypes of ionotropic glutamate receptors. Summation 
of subthreshold EPSCs in the postsynaptic neuron will eventually 
result in action potential firing and transmission of the pain mes-
sage to higher order neurons. Under these conditions, the NMDA 
subtype of glutamate channel is silent, but in the setting of injury, 
increased release of neurotransmitters from nociceptors will suf-
ficiently depolarize postsynaptic neurons to activate quiescent 
NMDA receptors. The consequent increase in calcium influx can 
strengthen synaptic connections between nociceptors and dor-
sal horn pain transmission neurons, which in turn will exacerbate 
responses to noxious stimuli (that is, generate hyperalgesia).
In many ways, this process is comparable to that implicated 
in the plastic changes associated with hippocampal long-term 
potentiation (LTP) (for a review on LTP in the pain pathway, see 
Drdla and Sandkuhler, 2008). Indeed, drugs that block spinal 
LTP reduce tissue injury-induced hyperalgesia. As in the case 
of hippocampal LTP, spinal cord central sensitization is depen-
dent on NMDA-mediated elevations of cytosolic Ca2+ in the 
postsynaptic neuron. Concurrent activation of metabotropic 
glutamate and substance P receptors on the postsynaptic neu-
ron may also contribute to sensitization by augmenting cytoso-
lic calcium. Downstream activation of a host of signaling path-
ways and second messenger systems, notably kinases (such 
as MAPK, PKA, PKC, PI3K, Src), further increases excitability 
of these neurons, in part by modulating NMDA receptor func-
tion (Latremoliere and Woolf, 2009). Illustrative of this model is 
the demonstration that spinal injections of a nine amino acid 
peptide fragment of Src not only disrupts an NMDA receptor-
Src interaction but also markedly decreases the hypersensi-
tivity produced by peripheral injury, without changing acute 
pain. Src null mutant mice also display reduced mechanical 
allodynia after nerve injury (Liu et al., 2008).
In addition to enhancing inputs from the site of injury (primary 
hyperalgesia), central sensitization contributes to the condition 
in which innocuous stimulation of areas surrounding the injury site can produce pain. This secondary hyperalgesia involves 
heterosynaptic facilitation, wherein inputs from Aβ afferents, 
which normally respond to light touch, now engage pain trans-
mission circuits, resulting in profound mechanical allodynia. 
The fact that compression block of peripheral nerve fibers con-
currently interrupts conduction in Aβ afferents and eliminates 
secondary hyperalgesia indicates that these abnormal circuits 
are established in clinical settings as well as in animal models 
(Campbell et al., 1988).
Loss of GABAergic and Glycinergic Controls: 
 Disinhibition
GABAergic or glycinergic inhibitory interneurons are densely 
distributed in the superficial dorsal horn and are at the basis 
of the longstanding gate control theory of pain, which postu-
lates that loss of function of these inhibitory interneurons (dis-
inhibition) would result in increased pain (Melzack and Wall, 
1965). Indeed, in rodents, spinal administration of GABA (bicu-
culline) or glycine (strychnine) receptor antagonists (Malan 
et al., 2002; Sivilotti and Woolf, 1994; Yaksh, 1989) produces 
behavioral hypersensitivity resembling that observed after 
peripheral injury. Consistent with these observations, periph-
eral injury leads to a decrease in inhibitory postsynaptic cur-
rents in superficial dorsal horn neurons. Although Moore et al. 
(2002) suggested that the disinhibition results from peripheral 
nerve injury-induced death of GABAergic interneurons, this 
claim has been contested (Polgar et al., 2005). Regardless of 
the etiology, the resulting decreased tonic inhibition enhances 
depolarization and excitation of projection neurons. As for 
NMDA-mediated central sensitization, disinhibition enhances 
spinal cord output in response to painful and nonpainful stimu-
lation, contributing to mechanical allodynia (Keller et al., 2007; 
Torsney and MacDermott, 2006).
Following up on an earlier report that deletion of the gene 
encoding PKCγ in the mouse leads to a marked decrease in 
nerve injury-evoked mechanical hypersensitivity (Malmberg 
et al., 1997), recent studies address the involvement of these 
neurons in the disinhibitory process. Thus, after blockade of 
glycinergic inhibition with strychnine, innocuous brushing of 
the hindpaw activates PKCγ-positive interneurons in lamina 
II (Miraucourt et al., 2007), as well as projection neurons in 
lamina I. Because PKCγ-positive neurons in the spinal cord 
are located only in the innermost part of lamina II (Figure 1), 
it follows that these neurons are essential for the expression 
of nerve injury-evoked persistent pain, and that disinhibitory 
mechanisms lead to their hyperactivation.
Other studies indicate that changes in the projection neu-
ron itself contribute to the disinhibitory process. For example, 
peripheral nerve injury profoundly downregulates the K+-Cl− 
cotransporter KCC2, which is essential for maintaining normal 
K+ and Cl− gradients across the plasma membrane (Coull et al., 
2003). Downregulation of KCC2, which is expressed in lamina I 
projection neurons, results in a shift in the Cl− gradient, such that 
activation of GABA-A receptors depolarizes, rather than hyper-
polarizes, the lamina I projection neurons. This would, in turn, 
enhance excitability and increase pain transmission. Indeed, 
pharmacological blockade or siRNA-mediated downregulation 
of KCC2 in the rat induces mechanical allodynia. Nonetheless, 
Zeilhofer and colleagues suggest that, even after injury, suf-Cell 139, October 16, 2009 ©2009 Elsevier Inc. 277
ficient inhibitory tone remains such that enhancement of spinal 
GABAergic neurotransmission might be a valuable approach to 
reduce pain hypersensitivity induced by peripheral nerve injury 
(Knabl et al., 2008). In fact, studies in mice suggest that drugs 
specifically targeting GABAA complexes containing a2 and/or 
a3 subunits reduce inflammatory and neuropathic pain without 
producing sedative-hypnotic side effects typically associated 
with benzodiazepines, which enhance activity of a1-containing 
channels.
Disinhibition can also occur through modulation of glycin-
ergic signaling. In this case, the mechanism involves a spinal 
cord action of prostaglandins (Harvey et al., 2004). Specifically, 
tissue injury induces spinal release of the prostaglandin, PGE2, 
which acts on EP2 receptors expressed by excitatory interneu-
rons and projection neurons in the superficial dorsal horn. 
Resultant stimulation of the cAMP-PKA pathway phospho-
rylates GlyRa3 glycine receptor subunits, rendering the neu-
rons unresponsive to the inhibitory effects of glycine. Accord-
ingly, mice lacking the GlyRa3 gene have decreased heat and 
mechanical hypersensitivity in models of tissue injury.
Glial-Neuronal Interactions
Finally, glial cells, notably microglia and astrocytes, also con-
tribute to the central sensitization process that occurs in the 
setting of injury. Under normal conditions, microglia function 
as resident macrophages of the central nervous system. They 
are homogeneously distributed within the gray matter of the 
spinal cord and are presumed to function as sentinels of injury 
or infection. Within hours of peripheral nerve injury, however, 
microglia accumulate in the superficial dorsal horn within the 
termination zone of injured peripheral nerve fibers. Microglia 
also surround the cell bodies of ventral horn motoneurons, 
whose peripheral axons are concurrently damaged. The acti-
vated microglia release a panoply of signaling molecules, 
including cytokines (such as TNF-a and interleukin-1β and 6), 
which enhance neuronal central sensitization and nerve injury-
induced persistent pain (DeLeo et al., 2007). Indeed, injection 
of activated brain microglia into the cerebral spinal fluid at the 
level of the spinal cord can reproduce the behavioral changes 
observed after nerve injury (Coull et al., 2005). Thus, it appears 
that microglial activation is sufficient to trigger the persistent 
pain condition (Tsuda et al., 2003).
As microglia are activated after nerve, but not inflammatory, 
tissue injury, it follows that activation of the afferent fiber, which 
occurs under both injury conditions, is not the critical trigger for 
microglial activation. Rather, physical damage of the peripheral 
afferent must induce the release of specific signals that are 
detected by microglia. Chief among these is ATP, which targets 
microglial P2-type purinergic receptors. Of particular interest 
are P2X4 (Tsuda et al., 2003), P2X7 (Chessell et al., 2005), and 
P2Y12 (Haynes et al., 2006; Kobayashi et al., 2008) receptor 
subtypes. Indeed, ATP was used to activate brain microglia in 
the spinal cord transplant studies referred to above (Tsuda et 
al., 2003). Furthermore, genetic or pharmacological blockade 
of purinergic receptor function (Chessell et al., 2005; Tozaki-
Saitoh et al., 2008; Ulmann et al., 2008) prevents or reverses 
nerve injury-induced mechanical allodynia (Honore et al., 2006; 
Kobayashi et al., 2008; Tozaki-Saitoh et al., 2008; Tsuda et al., 
2003).278 Cell 139, October 16, 2009 ©2009 Elsevier Inc.Coull and colleagues proposed a model in which ATP/P2X4-
mediated activation of microglia triggers a mechanism of dis-
inhibition (Coull et al., 2005). Specifically, they demonstrated 
that ATP-evoked activation of P2X4 receptors induces release 
of the brain-derived neurotrophic factor (BDNF) from microglia. 
The BDNF, in turn, acts upon TrkB receptors on lamina I projec-
tion neurons to generate a change in the Cl− gradient, which, as 
described above, would shift the action of GABA from hyper-
polarization to depolarization. Whether the BDNF-induced 
effect involves KCC2 expression, as occurs after nerve injury, 
is not known. Regardless of the mechanism, the net result is 
that activation of microglia will sensitize lamina I neurons such 
that their response to monosynaptic inputs from nociceptors, 
or indirect inputs from Aβ afferents, is enhanced.
In addition to BDNF, activated microglia, like peripheral mac-
rophages, release and respond to numerous chemokines and 
cytokines, and these also contribute to central sensitization. 
For example, in the uninjured (normal) animal, the chemokine 
fractalkine (CX3CL1) is expressed by both primary afferents 
and spinal cord neurons (Lindia et al., 2005; Verge et al., 
2004; Zhuang et al., 2007). In contrast, the fractalkine receptor 
(CX3CR1) is expressed on microglial cells and, importantly, is 
upregulated after peripheral nerve injury (Lindia et al., 2005; 
Zhuang et al., 2007). Because spinal delivery of fractalkine 
can activate microglia, it appears that nerve injury-induced 
release of fractalkine provides yet another route through which 
microglia can be engaged in the process of central sensitiza-
tion. Indeed blockade of CX3CR1 with a neutralizing antibody 
prevents both the development and maintenance of injury-
induced persistent pain (Milligan et al., 2004; Zhuang et al., 
2007). This pathway may also be part of a positive feedback 
loop through which injured nerve fibers and microglial cells 
interact in a reciprocal and recurrent fashion to amplify pain 
signals. This point is underscored by the fact that fractalkine 
must be cleaved from the neuronal surface prior to signaling, 
an action that is carried out by the microglial-derived protease, 
cathepsin S, inhibitors of which reduce nerve injury-induced 
allodynia and hyperalgesia (Clark et al., 2007). Importantly, 
spinal administration of cathepsin S generates behavioral 
hypersensitivity in wild-type but not CX3CR1 knockout mice, 
linking cathepsin S to fractalkine signaling (Clark et al., 2007; 
Zhuang et al., 2007). Although the factor(s) that initiates release 
of cathepsin S from microglia remains to be determined, ATP 
seems a reasonable possibility.
Very recently, several members of the Toll-like receptors 
(TLRs) family have also been implicated in the activation of 
microglia following nerve injury. TLRs are transmembrane sig-
naling proteins expressed in peripheral immune cells and glia. 
As part of the innate immune system, they recognize molecules 
that are broadly shared by pathogens. Genetic or pharmaco-
logical inhibition of TLR2, TLR3, or TLR4 function in mice results 
not only in decreased microglial activation, but also reduces 
the hypersensitivity triggered by peripheral nerve injury (Kim et 
al., 2007; Obata et al., 2008; Tanga et al., 2005). Unknown are 
the endogenous ligands that activate TLR2-4 after nerve injury. 
Among the candidates are mRNAs or heat shock proteins that 
could leak from the damaged primary afferent neurons and dif-
fuse into the extracellular milieu of the spinal cord.
The contribution of astrocytes to central sensitization is less 
clear. Astrocytes are unquestionably induced in the spinal cord 
after injury to either tissue or nerve (for a review, see Ren and 
Dubner, 2008). But, in contrast to microglia, astrocyte activa-
tion is generally delayed and persists much longer, up to sev-
eral months. One interesting possibility is that astrocytes are 
more critical to the maintenance, rather than to the induction of 
central sensitization and persistent pain.
Finally, it is worth noting that peripheral injury activates glia 
not only in the spinal cord, but also in the brainstem, where glia 
contribute to supraspinal facilitatory influences on the process-
ing of pain messages in the spinal cord (see Figure 2), a phe-
nomenon named descending facilitation (for a review, see Ren 
and Dubner, 2008). Such facilitation is especially prominent in 
the setting of injury and appears to counteract the feedback 
inhibitory controls that concurrently arise from various brain-
stem loci (Porreca et al., 2002).
Specificity in the Transmission and Control of Pain 
Messages
Understanding how stimuli are encoded by the nervous sys-
tem to elicit appropriate behaviors is of fundamental impor-
tance to the study of all sensory systems. In the simplest form, 
a sensory system uses labeled lines to transduce stimuli and 
elicit behaviors through strictly segregated circuits. This is per-
haps best exemplified by the taste system, where exchanging 
a sweet receptor for a bitter one in a population of “sweet taste 
afferents” does not alter the behavior provoked by activity in 
that labeled line; under these conditions, a bitter tastant stimu-
lates these afferents to elicit a perception of sweetness (Muel-
ler et al., 2005).
In the pain pathway, there is also evidence to support the 
existence of labeled lines. As mentioned above, heat and cold 
are detected by largely distinct subsets of primary afferent 
fibers. Moreover, elimination of subsets of nociceptors can 
produce selective deficits in the behavioral response to a par-
ticular noxious modality. For example, destruction of TRPV1-
expressing nociceptors produces a profound loss of heat pain 
(including heat hyperalgesia), with no change in sensitivity 
to painful mechanical or cold stimuli. Conversely, deletion of 
the MrgprD subset of nociceptors results in a highly selective 
deficit in mechanical responsiveness, with no change in heat 
sensitivity (Cavanaugh et al., 2009). Further evidence for func-
tional segregation at the level of the nociceptor comes from the 
analysis of two different opioid receptor subtypes (Scherrer et 
al., 2009). Specifically, the mu opioid receptor (MOR) predomi-
nates in the peptidergic population, whereas the delta opioid 
receptor (DOR) is expressed in nonpeptidergic nociceptors. 
MOR-selective agonists block heat pain, whereas DOR selec-
tive agonists block mechanical pain, again illustrating functional 
separation of molecularly distinct nociceptor populations.
These observations argue for behaviorally relevant specific-
ity at the level of the nociceptor. However, this is likely to be an 
oversimplification for at least two reasons. First, many nocice-
ptors are polymodal and can therefore be activated by thermal, 
mechanical, or chemical stimuli, leaving one to wonder how 
elimination of large cohorts of nociceptors can have modality-
specific effects. This argues for a substantial contribution of spinal circuits to the process whereby nociceptive signals are 
encoded into distinct pain modalities. Indeed, an important 
future goal is to better delineate neuronal subtypes within the 
dorsal horn and characterize their synaptic interactions with 
functionally or molecularly defined subpopulations of nocicep-
tors. Second, the pain system shows a tremendous capacity 
for change, particularly in the setting of injury, raising questions 
about whether and how a labeled line system might accommo-
date such plasticity, and how alterations in such mechanisms 
underlie maladaptive changes that produce chronic pain. 
Indeed, we know that substance P-saporin-mediated deletion 
of a discrete population of lamina I dorsal horn neurons, which 
express the substance P receptor, can reduce both the thermal 
and mechanical pain hypersensitivity that occurs after tissue 
or nerve injury (Nichols et al., 1999). Such observations sug-
gest that in the setting of injury specificity of the labeled line is 
not strictly maintained as information is transmitted to higher 
levels of the neuraxis.
Clearly, answers to these questions will require the combined 
use of anatomical, electrophysiological, and behavioral meth-
ods to map the physical and functional circuitry that underlies 
nociception and pain. The ongoing identification of molecules 
and genes that mark specific neuronal cell types (both periph-
eral and central) provides essential tools with which to manip-
ulate genetically or pharmacologically these neurons and to 
link their activities to specific components of pain behavior 
under normal and pathophysiological circumstances. Doing so 
should bring us closer to understanding how acute pain gives 
way to the maladaptive changes that produce chronic pain, 
and how this switch can be prevented or reversed.
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